Outcome of localized and metastatic germinoma treated according to SIOP CNS GCT 96

被引:0
|
作者
Calaminus, Gabriele [1 ]
Alapetite, Claire [2 ]
Frappaz, Didier [3 ]
Kortmann, Rolf-Dieter [4 ]
Garre, Maria Luisa
Saran, Frank
Ricardi, Umberto [5 ]
Nicholson, James [6 ]
机构
[1] Univ Munster, Munster, Germany
[2] Inst Curie, Paris, France
[3] Ctr Leon Berard, F-69373 Lyon, France
[4] Univ Leipzig, Leipzig, Germany
[5] Univ Turin, Turin, Italy
[6] Addenbrookes Hosp, Dept Pediat Oncol, Cambridge, England
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:420 / 420
页数:1
相关论文
共 50 条
  • [31] Outcome of patients with intracranial non-germinomatous germ cell tumors-lessons from the SIOP-CNS-GCT-96 trial
    Calaminus, Gabriele
    Frappaz, Didier
    Kortmann, Rolf Dieter
    Krefeld, Barbara
    Saran, Frank
    Pietsch, Torsten
    Vasiljevic, Alexandre
    Garre, Maria Luisa
    Ricardi, Umberto
    Mann, Jillian R.
    Gobel, Ulrich
    Alapetite, Claire
    Murray, Matthew J.
    Nicholson, James C.
    NEURO-ONCOLOGY, 2017, 19 (12) : 1661 - 1672
  • [32] Outcome of localized blastemal-type nephroblastoma patients treated according to intensified treatment in the SIOP 2001 protocol: A report of the SIOP-RTSG.
    Van den Heuvel-Eibrink, Marry M.
    van Tinteren, Harm
    Bergeron, Christophe
    Coulomb-Hermine, Aurore
    De Camargo, Beatriz
    Leuschner, Ivo
    Sandstedt, Bengt
    Garcia, Tomas Acha
    Gooskens, Saskia L.
    De Kraker, Jan
    Vujanic, Gordan M.
    Pritchard-Jones, Kathy
    Graf, Norbert
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [33] SIOP CNS GCT II: PRESENTATION AND OUTCOME OF BIFOCAL NON-GERMINOMATOUS GERM CELL TUMOURS (NGGCTS)
    Calaminus, Gabriele
    Kortmann, Rolf Dieter
    Alapetite, Claire
    Bison, Brigitte
    Frappaz, Didier
    Ajithkumar, Thankamma
    Gerber, Nicolas
    Peyrl, Andreas
    Morana, Giovanni
    Murray, Matthew
    Schoenberger, Stefan
    Brisse, Herve
    Zimmermann, Martin
    Nicholson, James
    Conter, Cecile Faure
    NEURO-ONCOLOGY, 2024, 26
  • [34] CNS germ cell tumours in children. Results of the German MAKEI 89 protocols and SIOP CNS GCT 93P/96 study
    Calaminus, G
    Garre, ML
    Kortmann, RD
    Mann, JR
    Gobel, U
    GERM CELL TUMOURS IV, 1998, : 247 - 254
  • [35] Endocrine disturbances and diabetes insipidus (DI) in patients with malignant CNS germ cell tumors: Clinical appearance and development under treatment in SIOP CNS GCT 96
    Corrias, A
    Garre, ML
    Frappaz, D
    Koch, S
    Nicholson, J
    Calaminus, G
    NEURO-ONCOLOGY, 2005, 7 (04) : 523 - 523
  • [36] Experience within the SIOP CNS GCT 96 trial SFOP studies with HDC/SCR in patients with CNS germ cell tumours and further implications for high risk patients
    Calaminus, G
    Patte, C
    BONE MARROW TRANSPLANTATION, 2002, 30 : S34 - S34
  • [37] RISK ADAPTED IRRADIATION IS FEASIBLE IN INTRACRANIAL NON-GERMINOMATOUS GERM CELL TUMOURS (NGGCT): FINAL RESULTS OF SIOP CNS GCT 96
    Calaminus, Gabriele
    Frappaz, Didier
    Kortmann, Rolf Dieter
    Alapetite, Claire
    Garre, Maria Luisa
    Ricardi, Umberto
    Saran, Frank Hans
    Nicholson, James
    NEURO-ONCOLOGY, 2012, 14 : 51 - 51
  • [38] 24 GY WHOLE VENTRICULAR RADIOTHERAPY ALONE IS SUFFICIENT FOR DISEASE CONTROL IN LOCALISED GERMINOMA IN CR AFTER INITIAL CHEMOTHERAPY - FINAL OF THE SIOP CNS GCT II STUDY
    Calaminus, Gabriele
    Bison, Brigitte
    Conter, Cecile Faure
    Frappaz, Didier
    Peyrl, Andreas
    Gerber, Nicolas U.
    Mueller, Jans-Enno
    Ajithkumar, Thankamma
    Morana, Giovanni
    Cross, Justin
    Pietsch, Torsten
    Smith, Colin
    Solem, Kristin
    Devenney, Irenne
    Garre, Maria Luisa
    Brisse, Herve
    Zimmermann, Martin
    Kortmann, Rolf-Dieter
    Alapetite, Claire
    Nicholson, James
    NEURO-ONCOLOGY, 2022, 24 : 56 - 56
  • [39] Quality of survival (QOS) in CNS germinoma (CNS-G) vs. CNS nongerminoma (CNS-NGGCTS) treated according to MAKEI 86/89
    Wiener, JA
    Calaminus, G
    Teske, C
    Weinspach, S
    Göbel, U
    NEURO-ONCOLOGY, 2005, 7 (04) : 525 - 525
  • [40] SIOP CNS GCT II: HIGH RISK (HR) CNS NON-GERMINOMATOUS GERM CELL TUMOURS (NGGCT) TREATED WITH DOSE INTENSIFIED PEI - FINAL RESULTS
    Calaminus, Gabriele
    Frappaz, Didier
    Ajithkumar, Thankamma
    Mueller, Jans-Enno
    Zimmermann, Martin
    Conter, Cecile Faure
    Timmermann, Beate
    Alapetite, Claire
    Murray, Matthew
    Garre, Maria Luisa
    Dieckmann, Karin
    Peyrl, Andreas
    Gerber, Nicolas U.
    Kortmann, Rolf-Dieter
    Nicholson, James
    NEURO-ONCOLOGY, 2022, 24 : 56 - 57